Health Technology Assessment in Egypt

The evaluation and assessment of the effectiveness, safety, and cost-effectiveness of health technologies.

A fragmented system with various public and private providers and funding sources.

A key goal in healthcare systems that strives to ensure all individuals have access to necessary healthcare services.

The Egyptian Authority for Unified Procurement, Medical Supply and the Management of Medical Technology.

The process of building skills and knowledge within an organization or system.

A structured process for analyzing the potential benefits and drawbacks of adopting new technologies or interventions.

A study based on firsthand observations and interactions with stakeholders.

A formal document summarizing the findings of an HTA study.

A plan or process for implementing a new health technology or intervention.

A systematic way to gather information to inform future HTA efforts. It analyzes the current state of the HTA system, identifies stakeholders and opportunities.

Collecting data to evaluate the impact of a HTA process. This involves tracking key indicators and measuring changes in healthcare outcomes.

The ability of a country or organization to successfully carry out HTA activities. It includes having skilled personnel, resources, and processes.

A systematic process to understand the needs and interests of different groups involved in HTA. It helps identify potential allies and barriers.

A method for gathering insights into stakeholders' perspectives on HTA. It assesses their awareness, opinions, needs, and expectations.

A critical step in establishing a new HTA policy. It helps build a foundation for effective HTA implementation.

The Egyptian healthcare system's objective to ensure affordable and accessible healthcare for all citizens by 2030.

A multidisciplinary process that analyzes the value of health technologies in terms of effectiveness, safety, and cost-effectiveness.

The Egyptian Authority for Unified Procurement, Medical Supply and the Management of Medical Technology. Responsible for procuring and managing medical supplies for the entire public healthcare system.

The law that establishes the legal framework for implementing Universal Health Insurance in Egypt.

A public service authority responsible for regulating pharmaceuticals, cosmetic products, and medical equipment in Egypt. Also sets public prices for new technologies.

The General Authority for Health Care (GAHC) is responsible for providing healthcare services and facilities to the public. It must obtain GAHAR accreditation before contracting with the UHIA.

The GAHAR accreditation process ensures that facilities meet the required standards for providing quality healthcare services.

A key mechanism in achieving UHC by facilitating strategic procurement, ensuring cost-effectiveness, and negotiating prices for health technologies.

The capacity of a country or organization to effectively conduct Health Technology Assessment (HTA) activities, including having skilled personnel, resources, and established processes.

A structured process that analyzes the current state of HTA within a specific region or organization, identifies key stakeholders, opportunities for improvement, and challenges.

The Egyptian Authority for Unified Procurement, Medical Supply, and the Management of Medical Technology. It plays a crucial role in procuring and managing medical supplies for the entire public healthcare system in Egypt.

A key goal in healthcare systems aimed at ensuring that all individuals have access to necessary healthcare services regardless of their ability to pay.

The process of building skills and knowledge within an organization or system to address specific needs. In HTA, this may involve training staff on HTA methods and processes.

The evaluation of the impact of a specific HTA process or intervention on healthcare outcomes and the health system. It's used to assess the effectiveness of implementing new technologies.

A collaborative effort between individuals and organizations involved in HTA, such as healthcare providers, researchers, policymakers, and industry representatives. This includes sharing information, resources, and expertise.

This refers to the choice of who to compare a new healthcare intervention to (e.g., standard care, another new treatment).

This refers to the group of individuals who are likely to benefit from a new healthcare intervention.

This involves analyzing the results of an HTA study in smaller, more specific sub-groups within the target population.

This refers to the time frame used to evaluate the costs and benefits of a healthcare intervention.

This is an important part of HTA which assesses the value of a healthcare intervention considering both its benefits and costs.

A systematic approach to identify and understand the interests, needs, and potential impacts of various groups involved in HTA. These groups can include patients, doctors, policymakers, industry representatives, and researchers.

Gathering information about stakeholders' awareness, opinions, needs, and expectations regarding HTA. It can involve surveys, interviews, or focus groups.

A structured process for implementing a new health technology or intervention - involves planning, resource allocation, and monitoring to ensure the successful adoption and delivery of the technology.